PKM and Nephropathy: Therefore, it may be speculated that, in diabetic patients without nephropathy, undetermined allosteric effectors stabilize PKM2 tetrameric assembly, thus favoring the glycolytic over the transcriptional regulator activity and the re-activation of mitochondrial oxidative metabolism.